Latest Blogs

Women in Oncology
Sep 16, 2021
The Glass Ceiling of Medical Oncology in MENA: Barely Scratching the Surface
Dr. Atlal Abusanad discusses how the underrepresentation of female oncologists in prominent roles is due to a bias in valuing their capability and potential. 
Don S. Dizon, MD, FACP, FASCO
Sep 14, 2021
When Cancer Comes Home
My colleague and friend Christine McGinn discusses the experience of caregiving for her brother, and the lessons she now brings to her own practice.
Guest Commentary
Sep 09, 2021
Studying During Fellowship: Tips to Build Your Knowledge Base
"I think of my fellowship studies as a series of layers—every time I do well at one layer, I am ready to move to the next one," said Dr. Tarek Haykal.
Linda R. Duska, MD, MPH
Sep 01, 2021
Clinical Research: Our Most Powerful Tool
There has never been a more exciting time to be involved in cancer research, with so much knowledge to support our explorations and so many pressing questions still to answer.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Jul 02, 2013
A Family Affair—A Weekend with the AMA House of Delegates
I just returned from an interesting family weekend. This family was the American Medical Association House of Delegates (AMA-HOD). I, along with Drs. Chris Nunnick, Barb McAneny, and ASCO staff, have had the pleasure of attending these meetings as a representative of ASCO for the past few years. It...
2 Comments
May 05, 2010
The beginnings of a new "guideline"
It seems like I've participated in every facet of the "ASCO guideline" process. During the past three years of being part of the HSC (now CPG) committee, I have been amazed to witness how complex and detailed developing a guideline can become. The manuscripts are reviewed at several levels and...
1 Comments

Pages